111 related articles for article (PubMed ID: 15963203)
1. Impaired endothelium-dependent flow-mediated dilation in Behçet's disease: more prominent endothelial dysfunction in patients with vascular involvement.
Oflaz H; Mercanoglu F; Karaman O; Kamali S; Erer B; Genchellac H; Pamukcu B; Umman S; Inanc M; Gul A
Int J Clin Pract; 2005 Jul; 59(7):777-81. PubMed ID: 15963203
[TBL] [Abstract][Full Text] [Related]
2. Association between the female athlete triad and endothelial dysfunction in dancers.
Hoch AZ; Papanek P; Szabo A; Widlansky ME; Schimke JE; Gutterman DD
Clin J Sport Med; 2011 Mar; 21(2):119-25. PubMed ID: 21358502
[TBL] [Abstract][Full Text] [Related]
3. Clinical assessment of endothelial function: ready for prime time?
Gokce N
Circ Cardiovasc Imaging; 2011 Jul; 4(4):348-50. PubMed ID: 21772010
[No Abstract] [Full Text] [Related]
4. Erythrocyte aggregation in Behçet's disease determined with the Sefam and Myrenne aggregometer. Lack of association with thrombosis and uveitis.
Ricart JM; Vayá A; Todolí J; Santaolaria ML; Calvo J; Aznar J
Clin Hemorheol Microcirc; 2005; 33(4):389-96. PubMed ID: 16317248
[TBL] [Abstract][Full Text] [Related]
5. Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behet disease.
Giansanti F; Barbera ML; Virgili L; Pieri B; Emmi L; Menchini U
Eur J Ophthalmol; 2004 Sep - Oct 2004; 14(5):445-448. PubMed ID: 28221491
[TBL] [Abstract][Full Text] [Related]
6. Levels of soluble E-selectin in patients with active Behçet's disease.
Sari RA; Kiziltunç A; Tays'y S; Akdem'yr S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 27520409
[TBL] [Abstract][Full Text] [Related]
7. Urinary 8-isoprostaglandin F(2alpha) level in Behçet's disease.
Ozdöl NC; Ateş A; Aydintuğ OT; Melli M
Prostaglandins Other Lipid Mediat; 2005 Dec; 78(1-4):96-106. PubMed ID: 16303608
[TBL] [Abstract][Full Text] [Related]
8. 5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement.
Ozkul Y; Evereklioglu C; Borlu M; Taheri S; Calis M; Dündar M; Ilhan O
Br J Ophthalmol; 2005 Dec; 89(12):1634-7. PubMed ID: 16299146
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the association between null genotypes of glutathione-S-transferases and Behcet's disease.
Uzunoğlu S; Acar H; Okudan N; Gökbel H; Mevlitoğlu I; Sari F
Arch Dermatol Res; 2006 Jan; 297(7):289-93. PubMed ID: 16283344
[TBL] [Abstract][Full Text] [Related]
10. Activation markers in Behçet's disease.
Coskun B; Saral Y; Gödekmerdan A; Erden I; Coskun N
Skinmed; 2005; 4(5):282-6. PubMed ID: 16282749
[TBL] [Abstract][Full Text] [Related]
11. Oxidative burst response to monosodium urate crystals in patients with Behçet's syndrome.
Gogus F; Fresko I; Elbir Y; Eksioglu-Demiralp E; Direskeneli H
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S81-5. PubMed ID: 16273771
[TBL] [Abstract][Full Text] [Related]
12. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome.
Fresko I; Ugurlu S; Ozbakir F; Celik A; Yurdakul S; Hamuryudan V; Yazici H
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S67-70. PubMed ID: 16273768
[TBL] [Abstract][Full Text] [Related]
13. Behçet's disease and hereditary periodic fever syndromes: casual association or causal relationship?
Espinosa G; Arostegui JI; Plaza S; Rius J; Cervera R; Yagüe J; Font J
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S64-6. PubMed ID: 16273767
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-18 gene polymorphisms in Korean patients with Behçet's disease.
Jang WC; Park SB; Nam YH; Lee SS; Kim JW; Chang IS; Kim KT; Chang HK
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S59-63. PubMed ID: 16273766
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic activity and d-dimer levels in Behçet's syndrome.
Yurdakul S; Hekim N; Soysal T; Fresko I; Bavunoglu I; Ozbakir F; Tabak F; Melikoglu M; Hamuryudan V; Yazici H
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S53-8. PubMed ID: 16273765
[TBL] [Abstract][Full Text] [Related]
16. Circulating soluble CD28 in patients with Behçet's disease: relationship to clinical manifestations.
Hamzaoui K; Hamzaoui A; Bouajina L; Houman H
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S49-52. PubMed ID: 16273764
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and monocyte chemoattractant protein-1 in Behçet's patients with venous thrombosis.
Bozoglu E; Dinc A; Erdem H; Pay S; Simsek I; Kocar IH
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S42-8. PubMed ID: 16273763
[TBL] [Abstract][Full Text] [Related]
18. Behçet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation.
Cuchacovich M; Merino G; Yamamoto JH; Villarroel F; Saavedra T; Jofre S; Gatica H; Velasquez V; Pizzo SV; Gonzalez-Gronow M
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S27-34. PubMed ID: 16273761
[TBL] [Abstract][Full Text] [Related]
19. Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature.
Kötter I; Koch S; Vonthein R; Rückwaldt U; Amberger M; Günaydin I; Zierhut M; Stübiger N
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S20-6. PubMed ID: 16273760
[TBL] [Abstract][Full Text] [Related]
20. Behçet's disease and other autoinflammatory conditions: what's in a name?
Yazici H; Fresko I
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S1-2. PubMed ID: 16273757
[No Abstract] [Full Text] [Related]
[Next] [New Search]
